Hi-TCR-T cells (multi-target)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hi-TCR-T cells (multi-target), covering 2025-09-03 to 2025-09-03. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]